This fund invests in a portfolio of 20 international healthcare giants. They include such widely recognized names as Johnson & Johnson, Merck, Pfizer, and Bristol-Myers Squibb as well as some companies you may not be familiar with like Quest Diagnostics and Anthem.
Income Investor
Sorry, you do not have access to this content.One of the attractions of this ETF is the consistency of its distributions. They have been maintained at US$0.0583 per month since the fund was launched. Assuming that rate continues, the forward yield is 8.2%. -Gordon Pape
Current Advice
Buy
Consult your broker/advisor
Capital Gain/Loss
5.2%
Interactive Performance Chart
HHL.U was first recommended here on July 2, 2018